Expression and occupancy of BAFF-R on B cells in systemic lupus erythematosus
about
B-Cell Activating Factor as a Cancer Biomarker and Its Implications in Cancer-Related CachexiaRegulatory roles of the tumor necrosis factor receptor BCMA.BAFF and BAFF-R of peripheral blood and spleen mononuclear cells in idiopathic thrombocytopenic purpura.Pathway of Toll-like receptor 7/B cell activating factor/B cell activating factor receptor plays a role in immune thrombocytopenia in vivo.Reduced tumour necrosis factor receptor superfamily 13C inversely correlated with tumour necrosis factor superfamily 13B in patients with immune thrombocytopenia.Investigations of a rabbit (Oryctolagus cuniculus) model of systemic lupus erythematosus (SLE), BAFF and its receptors.Systems biology of lupus: mapping the impact of genomic and environmental factors on gene expression signatures, cellular signaling, metabolic pathways, hormonal and cytokine imbalance, and selecting targets for treatment.High levels of B-cell activating factor in patients with active chronic graft-versus-host disease.Recovery of B-cell homeostasis after rituximab in chronic graft-versus-host disease.B lymphocyte stimulator (BLyS) isoforms in systemic lupus erythematosus: disease activity correlates better with blood leukocyte BLyS mRNA levels than with plasma BLyS protein levels.Update on the autoimmune pathology of multiple sclerosis: B-cells as disease-drivers and therapeutic targetsDecreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjögren's syndrome and systemic lupus erythematosus.Experimental Neuromyelitis Optica Induces a Type I Interferon Signature in the Spinal Cord.Requirement for BAFF and APRIL during B cell development in GALTExpression of BAFF and BR3 in patients with systemic lupus erythematosus.B lymphocytes as therapeutic targets in systemic lupus erythematosus.BAFF is increased in renal transplant patients following treatment with alemtuzumabAltered B-cell homeostasis and excess BAFF in human chronic graft-versus-host diseaseThe role of B lymphocyte stimulator (BLyS) in systemic lupus erythematosus.Expression and localization of rabbit B-cell activating factor (BAFF) and its specific receptor BR3 in cells and tissues of the rabbit immune system.Beyond transitional selection: New roles for BLyS in peripheral toleranceBiologic differences between various inhibitors of the BLyS/BAFF pathway: should we expect differences between belimumab and other inhibitors in development?Roles for BLyS family members in meeting the distinct homeostatic demands of innate and adaptive B cells.The role of B lymphocyte stimulator in B cell biology: implications for the treatment of lupus.The Role of BAFF System Molecules in Host Response to Pathogens.Anti-nuclear antibody production and autoimmunity in transgenic mice that overexpress the transcription factor Bright.Allogenic mesenchymal stem cell transplantation ameliorates nephritis in lupus mice via inhibition of B-cell activation.Expressions of BAFF/BAFF receptors and their correlation with disease activity in Chinese SLE patients.Delayed onset of autoreactive antibody production and M2-skewed macrophages contribute to improved survival of TACI deficient MRL-Fas/Lpr mouse.Association of BAFF, APRIL serum levels, BAFF-R, TACI and BCMA expression on peripheral B-cell subsets with clinical manifestations in systemic lupus erythematosus.Increased BCMA expression in lupus marks activated B cells, and BCMA receptor engagement enhances the response to TLR9 stimulation.The expression of BAFF-binding receptors is not altered in multiple sclerosis or myasthenia gravis.Profiling of B-Cell Factors and Their Decoy Receptors in Rheumatoid Arthritis: Association With Clinical Features and Treatment Outcomes
P2860
Q26784444-FDB06BD6-452F-4598-ACEE-31A5E344AEF4Q30422814-423DE9F1-0CB5-4CF3-B195-302C6620DBAEQ33381985-7F06F143-EBEE-4FB9-B58F-85DF7FE8FB12Q33396543-36D435A8-FEC1-4B7A-9256-69845F58F1C7Q33415681-41184C91-AD6A-42AA-9171-7D4D17814EA5Q33521234-8AF5E943-40BF-465B-BE1B-105600E2339AQ33608479-9BF6742E-F83D-48C9-A8C5-BE602D37DA44Q34135089-60F1E560-5502-46CB-8E85-18B0F4A43FE6Q34707354-CA144905-6823-4062-A1CA-C421630C803DQ34895937-4A44DB17-1CC9-4DB9-8BC4-A347ED093B6FQ35463552-B5D65F8A-1B59-4C5D-B3EE-7263DA34AEE6Q35953373-9DDFC44F-045D-4555-B3FD-384BB2CD60B9Q35962565-F810E752-650C-41C2-8C0E-1920543FC96BQ36135697-B984C9FF-6D0F-4F8A-9602-6BEEAA08A1DCQ36607723-53FAB347-847B-4C36-8645-2A56CE7B3AAEQ36653646-177FF2DB-9282-40D5-B1E1-EB885C7EECE1Q36925946-0D24434E-76DA-475A-A077-BC405EB5DB10Q37162874-70BB1D13-3484-487A-ACD4-472B5A5D3A69Q37170754-E6E38AF8-1116-4AE4-AA93-E84F56C6A5E4Q37348896-97D88600-C816-4EDB-B54D-76F11E731679Q37983058-BC976275-6CDD-4916-B219-1045913DA8C9Q38006643-88404D5E-F2FC-4FFF-85E3-C68472F8BE0EQ38084919-078DDEFC-4920-4AEB-A931-F08261CF6437Q38095861-F83C146C-A4C1-4DC3-A971-FFB789175D59Q38601694-F65394AC-AFE2-4DCA-8BCA-92BD6229CB81Q40240865-A119BC6B-A086-4AAB-85A9-7C00106A6978Q44985029-39BBB294-EB53-4191-875B-6B5E50A69116Q45285288-78DD661E-9E99-4A8A-993F-B4410386AC86Q47550170-9B80602D-F621-4A12-90AD-E0A3211D6381Q50705075-360281B8-508A-4C34-966B-9F5A921FB9C7Q51023029-054C067B-531A-4227-A191-6D30DB22D2DAQ51976061-44276B97-F643-4266-8D84-BB3116916482Q58122908-AAE2A2A7-6037-4339-B279-1DA24D8B0E37
P2860
Expression and occupancy of BAFF-R on B cells in systemic lupus erythematosus
description
article
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована у 2005
@uk
name
Expression and occupancy of BAFF-R on B cells in systemic lupus erythematosus
@en
Expression and occupancy of BAFF-R on B cells in systemic lupus erythematosus
@nl
type
label
Expression and occupancy of BAFF-R on B cells in systemic lupus erythematosus
@en
Expression and occupancy of BAFF-R on B cells in systemic lupus erythematosus
@nl
prefLabel
Expression and occupancy of BAFF-R on B cells in systemic lupus erythematosus
@en
Expression and occupancy of BAFF-R on B cells in systemic lupus erythematosus
@nl
P2093
P2860
P356
P1476
Expression and occupancy of BAFF-R on B cells in systemic lupus erythematosus
@en
P2093
Marc Pelletier
Robert H. Carter
Winn Chatham
Ximeng Liu
P2860
P304
P356
10.1002/ART.21489
P577
2005-01-01T00:00:00Z